Oncology Nursing News®

Register now to learn about a new option for relapsed or refractory follicular lymphoma

Gynecologic Cancers

Sequencing Ovarian Cancer Treatments Remains Challenging

Sequencing Ovarian Cancer Treatments Remains Challenging

BY BRITTANY LOVELY

FDA Approves Niraparib for Maintenance Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

FDA Approves Niraparib for Maintenance Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

BY BRIELLE BENYON

Racial Disparities Exist in Endometrial Cancer Care

Racial Disparities Exist in Endometrial Cancer Care

BY ELLIE LEICK

Pain, Stigma, and Other Gynecologic Cancer Issues

Pain, Stigma, and Other Gynecologic Cancer Issues

BY DON S. DIZON, MD, FACP

FDA Grants Dual Immunotherapy Regimen a Fast Track Designation for Cervical Cancer

FDA Grants Dual Immunotherapy Regimen a Fast Track Designation for Cervical Cancer

BY JASON M. BRODERICK

FDA Approves Cytology Test to Improve Prevention of Cervical Cancer

FDA Approves Cytology Test to Improve Prevention of Cervical Cancer

BY JASON M. BRODERICK

FDA Accepts BLA for Bevacizumab Biosimilar

FDA Accepts BLA for Bevacizumab Biosimilar

BY GINA COLUMBUS

FDA Accepts Niraparib Application for Frontline Maintenance Ovarian Cancer Treatment

BY JASON M. BRODERICK

PARP Inhibitor Becomes Standard of Care for Advanced Ovarian Cancer Subset

PARP Inhibitor Becomes Standard of Care for Advanced Ovarian Cancer Subset

BY BRIELLE BENYON

FDA Grants Priority Review to Olaparib Plus Bevacizumab for Frontline Maintenance in Ovarian Cancer

FDA Grants Priority Review to Olaparib Plus Bevacizumab for Frontline Maintenance in Ovarian Cancer

BY GINA COLUMBUS

External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc

OncNurse Resources

Newsroom
Continuing Education
Discussions
Web Exclusives

About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions

Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.